TY - JOUR
T1 - Anticoagulation and antiplatelet therapy in contact sports
T2 - Is it career limiting
AU - Kichloo, Asim
AU - Amir, Rawan
AU - Wani, Farah
AU - Randhawa, Sukhbir
AU - Rudd, Benjamin
AU - Rechlin, David
N1 - Publisher Copyright:
© American Federation for Medical Research 2021.No commercial re-use.See rights and permissions.Published by BMJ.
PY - 2021/3/1
Y1 - 2021/3/1
N2 - Medical conditions requiring treatment with anticoagulation (AC) or antiplatelet therapy have a huge burden on the average patient, but such conditions can have catastrophic effects on the careers of young, rising athletes, in particular those involved in contact sports at a professional level. Contact sports are defined as sports in which body-to-body contact is expected as part of the game such as football, basketball, soccer and hockey. The rates of injuries in these sports are high increasing the likelihood of bleeding event on AC. The main etiologies requiring AC and antiplatelets in athletes are venous thromboembolism and coronary artery disease, respectively. To date, there are no clear medical guidelines on the management of such conditions in athletes.
AB - Medical conditions requiring treatment with anticoagulation (AC) or antiplatelet therapy have a huge burden on the average patient, but such conditions can have catastrophic effects on the careers of young, rising athletes, in particular those involved in contact sports at a professional level. Contact sports are defined as sports in which body-to-body contact is expected as part of the game such as football, basketball, soccer and hockey. The rates of injuries in these sports are high increasing the likelihood of bleeding event on AC. The main etiologies requiring AC and antiplatelets in athletes are venous thromboembolism and coronary artery disease, respectively. To date, there are no clear medical guidelines on the management of such conditions in athletes.
KW - anticoagulants
KW - sports
UR - http://www.scopus.com/inward/record.url?scp=85098250574&partnerID=8YFLogxK
U2 - 10.1136/jim-2020-001658
DO - 10.1136/jim-2020-001658
M3 - Article
C2 - 33443051
AN - SCOPUS:85098250574
SN - 1081-5589
VL - 69
SP - 781
EP - 784
JO - Journal of Investigative Medicine
JF - Journal of Investigative Medicine
IS - 3
ER -